Secondary efficacy outcomes of top-pro study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine

Category Primary study
JournalJOURNAL OF THE NEUROLOGICAL SCIENCES
Year 2021
This article has no abstract
Epistemonikos ID: 509f57d7cbc9252c05155d1d2116a085257c3d13
First added on: Feb 13, 2025